Melasma

Latest News

New Trio Combination Cream Efficacious in Melasma Treatment
New Trio Combination Cream Efficacious in Melasma Treatment

August 29th 2023

A study found that a triple combination cream containing isobutylamido-thiazolyl-resorcinol, retinoic acid, and dexamethazone proved to be effective in treating melasma.

Systemic Oxidative Stress Plays Role in Etiopathogenesis of Melasma
Systemic Oxidative Stress Plays Role in Etiopathogenesis of Melasma

July 25th 2023

Blue Light Irradiation Induces Minimal Pigmentation Change in Patients With Melasma
Blue Light Irradiation Induces Minimal Pigmentation Change in Patients With Melasma

July 10th 2023

Microneedling Combined With Glutathione Promising in Treatment of Melasma
Microneedling Combined With Glutathione Promising in Treatment of Melasma

June 20th 2023

Latest CME Events & Activities

Advances in™ Hidradenitis Suppurativa (HS): Optimizing the Management Approach with Available and Emerging Treatments

View More

Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team

View More

Expert Illustrations and Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)

Register Now!

Best Practice in the Multidisciplinary Care of the Patient with HS

View More

Addressing Challenges in the Management of HS in Special Populations

View More

Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices

View More

Cases and Conversations™: Enhancing Diagnosis and Evaluation of Generalized Pustular Psoriasis in Advanced Practice Settings

View More

Community Practice Connections™: Multidisciplinary Management of BPDCN: Strategies for Differential Diagnosis and Integrating Novel Targeted Therapy

View More

Clinical ShowCase™ in Atopic Dermatitis: Personalized Management Plans for Pediatric Patients

View More

20th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

Facing the Changing Landscape for Neuromodulators and Dermal Fillers

View More

Advances In: Integrating New Treatment Options into Management Plans for Patients with Moderate-to-Severe Atopic Dermatitis

View More

Medical Crossfire®: Maximizing Patient Outcomes in Shingles – Are You Leveraging Guideline Based Care?

View More

"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation

View More

PER Skin Summit: Optimizing Diagnosis and Individualizing Management of Hidradenitis Suppurativa

View More

More News

© 2023 MJH Life Sciences

All rights reserved.